Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Arsalan Nisar, MS

Articles by Arsalan Nisar, MS

Ktsdesign/AdobeStock

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review

ByParas Gupta, MBE,Sarah Hakam, BS,Arsalan Nisar, MS,Inna D'Empaire, MD,Gina Jamal, MD,Reza Safavi, MD

February 3rd 2025

What patients are at risk when taking SSRIs?

Latest Updated Articles

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review
February 3rd 2025

Trending on Psychiatric Times

Sleep Disruption and Alzheimer Disease: A Bidirectional, Treatable Relationship

FDA Aligns on Key Elements of Phase 3 Study of Zervimesine for Dementia With Lewy Bodies

MDD Side Effect Profiles: Counseling, Adherence, and Suicidality Monitoring

Synapse-Level Mapping Could Reveal How Disrupted Brain Circuits Lead to Psychiatric Disorders

Revisiting MDD Management in Primary Care